Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
Operating Income
Avid Bioservices Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avid Bioservices Inc
NASDAQ:CDMO
|
Operating Income
-$22.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
7%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Operating Income
$19.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Operating Income
$11.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-6%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Operating Income
$16.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
Operating Income
-$136.5m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-17%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Operating Income
$4.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Avid Bioservices Inc
Glance View
Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
See Also
What is Avid Bioservices Inc's Operating Income?
Operating Income
-22.3m
USD
Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Operating Income amounts to -22.3m USD.
What is Avid Bioservices Inc's Operating Income growth rate?
Operating Income CAGR 10Y
7%
Over the last year, the Operating Income growth was -86%.
